Department Of Pharmacy 3
101. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
102. Involvement of 3′,5′-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone
103. Involvement of 3′,5′-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone
104. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
105. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
106. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
107. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
108. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
109. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
110. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
111. COMPARATIVE STUDY OF ANTIBACTERIAL EFFECTS OF MODIFIED PREPARATIONS CONTAINING METAL NANOPARTICLES
112. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
113. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
114. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
115. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
116. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
117. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
118. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
119. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
120. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
121. Prioritizing safe schools in Nigeria: A key to sustainable educational development [commentary]
122. Prioritizing safe schools in Nigeria: A key to sustainable educational development [commentary]
123. GC/MS chemical profiling and isolation of secondary metabolites from Leontice ewersmannii
124. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
125. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
126. FT-IR and GC–MS analyses and antioxidant activities of extracts of the wild type Saussurea sordida and Saussurea alpina native to Kazakhstan
127. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
128. Correction of hypoxic effects on target organs in pneumonia with phytotherapy
129. Adipocytokine imbalance and breast cancer in obese women
130. Investigating the Effect of Streptozotocin Induced Diabetes on the Ovarian Tissue of Nmri Mice Following the Injection of MgO and MgO NPs
131. Therapeutic potential of herbal medicine for the management of hyperlipidemia: latest updates
132. Therapeutic potential of herbal medicine for the management of hyperlipidemia: latest updates
133. Therapeutic potential of herbal medicine for the management of hyperlipidemia: latest updates
134. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
135. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
136. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
137. The buffering effects of mindfulness and organizational support on the mental health of hospital pharmacists in high-workload environments
138. Identification of avian pathogenic E. coli O (somatic) antigens
139. Floral extracts-mediated green synthesis of NiO nanoparticles and their diverse pharmacological evaluations
140. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
141. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
142. Heterocyclic aromatic amines in food as mutagenesis factors
143. Surgical treatment of patientswithconvergent concomitant strabismus: clinical effectiveness and long-term outcomes
144. Mapping routine measles vaccination in low- and middle-income countries
145. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
146. Results of social research on assessing the needs for pharmaceutical personnel
147. Anticancer potential of decursin, decursinol angelate, and decursinol from Angelica gigas Nakai: A comprehensive review and future therapeutic prospects
148. Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
149. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
150. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
1 2 3 4